Ubs Group Ag Affimed N.V. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.66 - $1.29 $9,226 - $18,032
13,979 Added 42.24%
47,073 $35,000
Q4 2022

Feb 08, 2023
BUY
$1.1 - $2.45 $36,403 - $81,080
33,094 New
33,094 $41,000
Q2 2022

Aug 10, 2022
SELL
$2.27 - $4.86 $101,820 - $217,995
-44,855 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$3.69 - $5.65 $191 - $293
-52 Reduced 0.12%
44,855 $196,000
Q4 2021

Feb 14, 2022
BUY
$5.37 - $7.07 $241,150 - $317,492
44,907 New
44,907 $248,000
Q2 2021

Aug 13, 2021
SELL
$7.78 - $11.4 $108,398 - $158,836
-13,933 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$5.12 - $8.48 $38,435 - $63,659
7,507 Added 116.82%
13,933 $110,000
Q4 2020

Feb 11, 2021
BUY
$3.16 - $7.03 $19,042 - $42,362
6,026 Added 1506.5%
6,426 $37,000
Q3 2020

Nov 12, 2020
SELL
$3.26 - $4.73 $55,700 - $80,816
-17,086 Reduced 97.71%
400 $1,000
Q2 2020

Jul 31, 2020
SELL
$1.58 - $4.63 $24,627 - $72,167
-15,587 Reduced 47.13%
17,486 $81,000
Q1 2020

May 01, 2020
SELL
$1.44 - $3.02 $76,091 - $159,579
-52,841 Reduced 61.5%
33,073 $53,000
Q4 2019

Feb 14, 2020
BUY
$2.25 - $3.07 $64,113 - $87,479
28,495 Added 49.63%
85,914 $235,000
Q3 2019

Nov 14, 2019
BUY
$2.67 - $3.65 $123,236 - $168,469
46,156 Added 409.8%
57,419 $169,000
Q2 2019

Aug 14, 2019
BUY
$2.6 - $4.21 $25,643 - $41,523
9,863 Added 704.5%
11,263 $32,000
Q1 2019

May 14, 2019
BUY
$3.05 - $4.34 $3,050 - $4,340
1,000 Added 250.0%
1,400 $6,000
Q4 2018

Feb 14, 2019
SELL
$2.82 - $4.67 $21,166 - $35,053
-7,506 Reduced 94.94%
400 $1,000
Q3 2018

Nov 14, 2018
SELL
$1.45 - $6.15 $63,305 - $268,502
-43,659 Reduced 84.67%
7,906 $34,000
Q2 2018

Aug 14, 2018
BUY
$1.65 - $2.5 $83,767 - $126,920
50,768 Added 6369.89%
51,565 $85,000
Q1 2018

May 15, 2018
BUY
$1.25 - $2.65 $496 - $1,052
397 Added 99.25%
797 $2,000
Q4 2017

Feb 14, 2018
SELL
$1.23 - $2.3 $2,044 - $3,822
-1,662 Reduced 80.6%
400 $1,000
Q3 2017

Nov 14, 2017
SELL
$1.95 - $2.25 $1,552 - $1,791
-796 Reduced 27.85%
2,062 $5,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,858
2,858 $6,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $520M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email